NSE ScannerComparison · NSE · data 2026-10-30
Divi's Laboratories Limited vs Sun Pharmaceutical Industries Limited
In plain words
Size: Sun Pharmaceutical Industries Limited is about 1.7 times the market value of Divi's Laboratories Limited.
Valuation (P/E): Divi's Laboratories Limited 88.8 vs Sun Pharmaceutical Industries Limited 35.3.
Profit growth over 3 years: Divi's Laboratories Limited 12.1% a year vs Sun Pharmaceutical Industries Limited 10.6% a year.
Debt to equity: Sun Pharmaceutical Industries Limited 0.06 vs Divi's Laboratories Limited 0.
Differences in the numbers, not a recommendation of either stock.
Side by side
| DIVISLAB | SUNPHARMA | |
|---|---|---|
| Price | ₹9,780 | ₹1,777.7 |
| Market cap | ₹2,56,310 cr | ₹4,22,981 cr |
| P/E | 88.8 | 35.3 |
| P/B | — | — |
| ROE | 16.2% | 14.7% |
| ROCE | 18.0% | 17.7% |
| Debt / equity | 0 | 0.06 |
| Operating margin | 31.0% | 22.9% |
| Dividend yield | 0.31% | 0.91% |
| Sales growth, 3 years (yearly) | 10.8% | 9.9% |
| Profit growth, 3 years (yearly) | 12.1% | 10.6% |
| 1-year return | 49.4% | 3.6% |
| Revenue, last 12 months | ₹11,230 cr | ₹59,911 cr |
| Net profit, last 12 months | ₹2,925 cr | ₹12,096 cr |
| Latest quarter | Dec 2025 | Dec 2024 |
| Quarter net profit | ₹583 cr | ₹2,903 cr |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | 51.88% | 54.48% |
| Health check | Average (6.4/10) | Strong (7/10) |
Common questions
Which has a higher P/E, Divi's Laboratories Limited or Sun Pharmaceutical Industries Limited?
Divi's Laboratories Limited trades at the higher P/E (88.8 against 35.3). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Divi's Laboratories Limited (16.2% against 14.7%).
Which carries more debt?
Sun Pharmaceutical Industries Limited has the higher debt-to-equity ratio (0.06 against 0).